| Entry |
|
|---|
| Name |
Debrisoquin;
Debrisoquine
|
|---|
| Formula |
C10H13N3
|
|---|
| Exact mass |
175.1109
|
|---|
| Mol weight |
175.2303
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C02 ANTIHYPERTENSIVES
C02C ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING
C02CC Guanidine derivatives
C02CC04 Debrisoquine
C13650 Debrisoquin
Drug groups [BR:br08330]
Cardiovascular agent
DG01739 Peripherally-acting antiadrenergic
DG00259 Debrisoquine
C13650 Debrisoquin
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 13
1 C8x C 23.7750 -16.4013
2 C8x C 23.7750 -17.8010
3 C8x C 24.9872 -18.5009
4 C8y C 26.1994 -17.8010
5 C8y C 26.1994 -16.4013
6 C8x C 24.9872 -15.7015
7 C1x C 27.4116 -18.5009
8 C1x C 28.6238 -17.8010
9 N1y N 28.6238 -16.4013
10 C1x C 27.4116 -15.7015
11 C2c C 29.8386 -15.7000
12 N1a N 31.0529 -16.4009
13 N2a N 29.8386 -14.3017
BOND 14
1 1 2 1
2 2 3 2
3 3 4 1
4 4 5 2
5 5 6 1
6 1 6 2
7 4 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 5 10 1
12 9 11 1
13 11 12 1
14 11 13 2
|
|---|
